Huapont Life Sciences Co Ltd Cash Flow Reinvestment Rate
Huapont Life Sciences Co Ltd cash flow reinvestment rate. Huapont Life Sciences Co Ltd (002004) has a Cash Flow Reinvestment Rate of 0.25x as of September 2025, reinvesting CN¥160.05 Million (capex CN¥160.05 Million ) from operating cash flow of CN¥635.17 Million. Explore Huapont Life Sciences Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Huapont Life Sciences Co Ltd (2002–2025)
Cash flow reinvestment rate of Huapont Life Sciences Co Ltd from 2002 to 2025. Historical reinvestment intensity for Huapont Life Sciences Co Ltd across 24 annual periods. Explore capital reinvestment ratio of Huapont Life Sciences Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Huapont Life Sciences Co Ltd Cash Flow Reinvestment Rate by Year (2002–2025)
Huapont Life Sciences Co Ltd cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Huapont Life Sciences Co Ltd. For the full cash flow conversion analysis, see Huapont Life Sciences Co Ltd (002004) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.32 Billion | CN¥2.10 Billion | CN¥638.28 Million | ▼ -15.1% |
| 2024 | 0.74x | CN¥1.20 Billion | CN¥1.63 Billion | CN¥956.27 Million | ▼ -21.3% |
| 2023 | 0.94x | CN¥1.50 Billion | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +32.0% |
| 2022 | 0.71x | CN¥1.72 Billion | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -41.9% |
| 2021 | 1.23x | CN¥1.56 Billion | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +51.9% |
| 2020 | 0.81x | CN¥1.92 Billion | CN¥2.37 Billion | CN¥1.23 Billion | ▲ +1.2% |
| 2019 | 0.80x | CN¥1.66 Billion | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +1.1% |
| 2018 | 0.79x | CN¥1.51 Billion | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -53.9% |
| 2017 | 1.71x | CN¥1.01 Billion | CN¥591.40 Million | CN¥972.67 Million | ▼ -76.2% |
| 2016 | 7.18x | CN¥3.68 Billion | CN¥511.90 Million | CN¥651.24 Million | ▲ +189.1% |
| 2015 | 2.48x | CN¥850.93 Million | CN¥342.45 Million | CN¥831.76 Million | ▲ +93.5% |
| 2014 | 1.28x | CN¥585.54 Million | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥379.81 Million | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥315.21 Million | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥95.77 Million | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥56.87 Million | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥73.46 Million | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥92.49 Million | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥124.02 Million | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥47.76 Million | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥44.42 Million | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥26.83 Million | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥30.82 Million | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥52.71 Million | CN¥36.88 Million | CN¥52.71 Million | — |